Clinical Trial of Autologous Tcm Immunotherapy in ICC

Clinical trial NCT03820310 · UNKNOWN

Trial details

NCT number: NCT03820310
Sponsor: Newish Technology (Beijing) Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2018-05-01
Primary completion: 2025-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.